Conjugated oligoelectrolytes overcome cancer drug resistance by dual-mode lysosomal membrane disruption

Abstract

Aim: Multidrug resistance (MDR) often arises from lysosomal sequestration of chemotherapeutics. This study aims to design and evaluate lysosome-targeting membrane-intercalating conjugated oligoelectrolytes (MICOEs) for their potential to reverse MDR via dual-mode lysosomal membrane disruption, and to identify the most effective candidate.

Methods: Three MICOEs featuring a pyridothiadiazole-thienothiophene-pyridothiadiazole (PTTP) conjugated backbone with quaternary ammonium-terminated 4-, 6-, and 8-carbon alkyl chains at both ends (PTTP-DC4, PTTP-DC6, PTTP-DC8) were synthesized and characterized. Their photophysical properties, cellular uptake, and sublocalization were assessed in doxorubicin (DOX)-resistant Michigan Cancer Foundation-7/adriamycin-resistant (MCF-7/ADR) cells. Lysosomal integrity and contents release were evaluated via acridine orange and cathepsin B assays. Proteomic analysis was performed to uncover mechanisms. The combinational effect of PTTP-DC6 and DOX was tested in drug-resistant two-dimensional (2D) and three-dimensional (3D) cell models.

Results: Among PTTP-DCns (where n = 4, 6, and 8, corresponding to PTTP-DC4, PTTP-DC6, and PTTP-DC8), PTTP-DC6 showed optimal lysosomal accumulation and induced lysosomal membrane permeabilization (LMP) through both physical membrane interaction and light-triggered reactive oxygen species generation. Proteomic analysis revealed significant enrichment of pathways associated with oxidative stress and lysosomal dysfunction. Pretreatment with PTTP-DC6 at low doses, particularly under mild light irradiation, significantly enhanced DOX sensitivity in resistant 2D monolayers and 3D spheroid models.

Conclusion: PTTP-DC6 overcomes MDR by dual-mode LMP induction, providing a simple strategy to resensitize resistant cancers to conventional chemotherapy.

Keywords

Membrane-intercalating conjugated oligoelectrolytes / lysosomal membrane permeabilization / drug resistance / combination therapy

References

[1] Miller KD,Devasia T.Cancer treatment and survivorship statistics, 2022.CA Cancer J Clin2022;72:409-36

[2] Emran TB,Mahmud AR.Multidrug resistance in cancer: understanding molecular mechanisms, immunoprevention and therapeutic approaches.Front Oncol2022;12:891652 PMCID:PMC9262248

[3] Longley DB.Molecular mechanisms of drug resistance.J Pathol2005;205:275-92

[4] Bukowski K,Kontek R.Mechanisms of multidrug resistance in cancer chemotherapy.Int J Mol Sci2020;21:3233 PMCID:PMC7247559

[5] Geisslinger F,Vollmar AM.Targeting lysosomes in cancer as promising strategy to overcome chemoresistance - a mini review.Front Oncol2020;10:1156 PMCID:PMC7363955

[6] Zhitomirsky B.Lysosomes as mediators of drug resistance in cancer.Drug Resist Updat2016;24:23-33

[7] Chauhan N.Emerging roles of lysosome homeostasis (repair, lysophagy and biogenesis) in cancer progression and therapy.Cancer Lett2024;584:216599

[8] Trybus W,Król T.Lysosomes as a target of anticancer therapy.Int J Mol Sci2023;24:2176 PMCID:PMC9916765

[9] Cuesta-Casanovas L,Cornet-Masana JM,Clément-Demange L.Lysosome-mediated chemoresistance in acute myeloid leukemia.Cancer Drug Resist2022;5:233-44 PMCID:PMC8992599

[10] Liverani C,Spadazzi C.Lineage-specific mechanisms and drivers of breast cancer chemoresistance revealed by 3D biomimetic culture.Mol Oncol2022;16:921-39 PMCID:PMC8847989

[11] Xu Z,Li X,Cheng B.Glucuronidase-instructed glycopeptide self-assembly for selective killing of cancer cells through lysosomal membrane permeabilization.Angew Chem Int Ed Engl2025:e202420596

[12] Zhitomirsky B.Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance.Oncotarget2015;6:1143-56 PMCID:PMC4359223

[13] Hu M, Carraway KL 3rd. Repurposing cationic amphiphilic drugs and derivatives to engage lysosomal cell death in cancer treatment.Front Oncol2020;10:605361 PMCID:PMC7793984

[14] Keum C,Kim D,Kim H.Lysosome-instructed self-assembly of amino-acid-functionalized perylene diimide for multidrug-resistant cancer cells.ACS Appl Mater Interfaces2021;13:14866-74

[15] Wang J,Wang H.Harnessing endocytic pH gradients for cascaded formation of intracellular condensates to inhibit autophagy: a pathway to cancer therapy.Nano Today2024;57:102317

[16] Chen Y,Wang S.Boosting ROS-mediated lysosomal membrane permeabilization for cancer ferroptosis therapy.Adv Healthc Mater2023;12:e2202150

[17] Kim JW,Kim D.GPX4 overexpressed non-small cell lung cancer cells are sensitive to RSL3-induced ferroptosis.Sci Rep2023;13:8872 PMCID:PMC10232506

[18] Muhammad P,Li J.Carbon dots supported single Fe atom nanozyme for drug-resistant glioblastoma therapy by activating autophagy-lysosome pathway.Nano Today2022;45:101530

[19] Xu S,Hu X.A dual chemodrug-loaded hyaluronan nanogel for differentiation induction therapy of refractory AML via disrupting lysosomal homeostasis.Sci Adv2025;11:eado3923 PMCID:PMC11952094

[20] Xiang Y,Liu M.Nanodrugs detonate lysosome bombs.Front Pharmacol2022;13:909504 PMCID:PMC9152002

[21] Yan H,Bazan GC.Membrane-intercalating conjugated oligoelectrolytes: impact on bioelectrochemical systems.Adv Mater2015;27:2958-73

[22] Zhou C,Yong KT.Membrane-intercalating conjugated oligoelectrolytes.Chem Soc Rev2022;51:9917-32

[23] Leifert D,Limwongyut J,Bazan GC.Photoswitchable conjugated oligoelectrolytes for a light-induced change of membrane morphology.Angew Chem Int Ed Engl2020;59:20333-7

[24] Limwongyut J,Moreland AS.Molecular design of antimicrobial conjugated oligoelectrolytes with enhanced selectivity toward bacterial cells.Chem Sci2020;11:8138-44 PMCID:PMC8163332

[25] Moreland AS,Holton SJ.Structural modulation of membrane-intercalating conjugated oligoelectrolytes decouples outer membrane permeabilizing and antimicrobial activities.Chem Commun2023;59:12172-5

[26] Wang B,Rengert ZD,Bazan GC.Conjugated oligoelectrolytes: materials for acceleration of whole cell biocatalysis.Chem Mater2018;30:5836-40

[27] Wang B,Mikhailovsky A,Bazan GC.A membrane-intercalating conjugated oligoelectrolyte with high-efficiency photodynamic antimicrobial activity.Angew Chem Int Ed Engl2017;56:5031-4

[28] Du C,Gao M.Property regulation of conjugated oligoelectrolytes with polyisocyanide to achieve efficient photodynamic antibacterial biomimetic hydrogels.ACS Appl Mater Interfaces2021;13:27955-62

[29] Large DE,Fink EA.Liposome composition in drug delivery design, synthesis, characterization, and clinical application.Adv Drug Delivery Rev2021;176:113851

[30] Lombardo D.Methods of liposomes preparation: formation and control factors of versatile nanocarriers for biomedical and nanomedicine application.Pharmaceutics2022;14:543 PMCID:PMC8955843

[31] Wood CA,Kim CS.Clinically translatable quantitative molecular photoacoustic imaging with liposome-encapsulated ICG J-aggregates.Nat Commun2021;12:5410 PMCID:PMC8438038

[32] Ishow E,Miomandre F,Buntinx G.Comprehensive investigation of the excited-state dynamics of push-pull triphenylamine dyes as models for photonic applications.Phys Chem Chem Phys2013;15:13922-39

[33] Rennick JJ,Parton RG.Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics.Nat Nanotechnol2021;16:266-76

[34] Maruoka N,Omata N.Effects of chlorpromazine on plasma membrane permeability and fluidity in the rat brain: a dynamic positron autoradiography and fluorescence polarization study.Prog Neuropsychopharmacol Biol Psychiatry2007;31:178-86

[35] Pawlikowska-Pawlęga B,Jarosz-Wilkołazka A.Biophysical characterization of genistein-membrane interaction and its correlation with biological effect on cells - the case of EYPC liposomes and human erythrocyte membranes.Biochim Biophys Acta2014;1838:2127-38

[36] Boya P.Lysosomal membrane permeabilization in cell death.Oncogene2008;27:6434-51

[37] Dou Y, Kawaler EA, Zhou DC, et al.; Clinical Proteomic Tumor Analysis Consortium. Proteogenomic characterization of endometrial carcinoma.Cell2020;180:729-48.e26 PMCID:PMC7233456

[38] Song Q,Jiang D.Proteomic analysis reveals key differences between squamous cell carcinomas and adenocarcinomas across multiple tissues.Nat Commun2022;13:4167 PMCID:PMC9293992

[39] Xu S,Cai Y.Using clusterProfiler to characterize multiomics data.Nat Protoc2024;19:3292-320

[40] Pampaloni F,Stelzer EHK.The third dimension bridges the gap between cell culture and live tissue.Nat Rev Mol Cell Biol2007;8:839-45

[41] Zanoni M,Arienti C.3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained.Sci Rep2016;6:19103 PMCID:PMC4707510

[42] Repnik U,Turk B.Lysosomal membrane permeabilization in cell death: concepts and challenges.Mitochondrion2014;19 Pt A:49-57

[43] Qiao L,Qiu X.LAMP2A, LAMP2B and LAMP2C: similar structures, divergent roles.Autophagy2023;19:2837-52 PMCID:PMC10549195

[44] Tan JX.A phosphoinositide signalling pathway mediates rapid lysosomal repair.Nature2022;609:815-21 PMCID:PMC9450835

[45] Lu H,Luo R.Engineered hybrid cell membrane nanosystems for treating cardiovascular diseases.Mater Today Bio2025;33:101992 PMCID:PMC12264635